AMSTERDAM: Wolters Kluwer Health has acquired NurseTim, a US-based provider of nursing education solutions. NurseTim will become part of Wolters Kluwer’s Health Learning, Research & Practice (HLRP) business, which includes nursing education and practice solutions that help ensure students are ready for practice and nurses are prepared to deliver better patient care and outcomes. NurseTim’s…
EUROAPI to invest €40 million for a more efficient and sustainable production in France
PARIS, FRANCE: EUROAPI has approved a €40 million investment for the implementation of a new production technology dedicated to vitamin B12 at its site in Saint-Aubin-lès-Elbeuf (Seine-Maritime, France). The project should enable EUROAPI to increase its manufacturing capacity by 2025 while reducing its environmental footprint. This investment benefits from a total financial support of €7.9…
Ipsen to acquire Albireo for an initial $952 million
PARIS, FRANCE: Ipsen and Albireo have entered into a definitive merger agreement under which Ipsen will acquire Albireo, a leading innovator in bile-acid modulators to treat pediatric and adult cholestatic liver diseases. The anticipated acquisition will enrich Ipsen’s Rare Disease portfolio and pipeline. The lead medicine in Albireo’s pipeline is Bylvay® (odevixibat), a potent, once-daily,…
AstraZeneca partners LBT Innovations for APAS pharma development
ADELAIDE, AUSTRALIA: Australian medical technology company LBT Innovations Limited (ASX: LBT) has been engaged by AstraZeneca for the full product development for its APAS Pharma product. LBT Innovations has been engaged by AstraZeneca, a global biopharmaceutical company, to undertake a full product development project for the Company’s new APAS® Pharma analysis module (artificial intelligence software)…
Forever Cheese has acquired the assets of W.A. Imports Inc.
NEW YORK: Forever Cheese, a leading specialty foods importer, has acquired substantially the assets of W.A. Imports Inc. headquartered in Hebron, IL. W.A. Imports is an importer and manufacturer of premium Japanese food products and ingredients sought after by chefs, mixologists, and consumers including Haku® Mizunara Whisky Barrel Aged Shoyu, CalPAC® Black Garlic Molasses, and…
Wag! signs deal to acquire Dog Food Advisor for $9 million
SAN FRANCISCO: Wag! Group Co. entered into a definitive asset purchase agreement with Clicks and Traffic LLC to purchase its Dog Food Advisor assets for cash consideration of $9 million. The transaction, which remains subject to customary closing conditions, is expected to close during the first quarter of 2023. Dog Food Advisor is one of…
Arovella Therapeutics appoints Dr Nicole van der Weerden as Chief Operating Officer
MELBOURNE, AUSTRALIA: Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company focused on developing its invariant Natural Killer T (iNKT) cell platform to treat cancer, announced that Dr Nicole van der Weerden has been appointed to the role of Chief Operating Officer, commencing 4 January 2023. Dr van der Weerden brings over 15 years of strong…
Hotel Chocolat Group signs strategic partnership agreement with Eat Creator Corporation
LONDON: Hotel Chocolat Group plc, a premium chocolate maker, has signed a new strategic partnership agreement with Tokyo-based Eat Creator Corporation. Satoshi Nagasuna, Eat Creator Corporation CEO, commented: “Like many Japanese people, I have watched the positive impact that the Hotel Chocolat brand has made in our market over the last four challenging years. When…
Hikma launches authorized generic of Xyrem (sodium oxybate) in the US
LONDON: Hikma Pharmaceuticals has launched an authorized generic version of Jazz Pharmaceuticals’ Xyrem (sodium oxybate) oral solution CIII. Hikma will have 180 days of marketing exclusivity for its authorized generic product in the US. Sodium Oxybate oral solution, 0.5 g/mL is a prescription medicine used to treat the following symptoms in people 7 years of…
Flora Growth Corp. acquires Franchise Global Health, Germany based medical cannabis operator
TORONTO: Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator, manufacturer and distributor of global cannabis products and brands, has completed the acquisition of Franchise Global Health Inc. (TSXV: FGH), a multi-national operator in the medical cannabis and pharmaceutical industry, with principal operations in Germany. “We view this acquisition as transformational as Flora pursues its…